Decreasing Treatment Burdens with Second Generation Anti-VEGF Agents

Review findings from recent studies and clinical trials on surgical interventions and medical therapies to manage proliferative vitreoretinopathy (PVR).

Sit down with Sumitra Khandelwal, MD, to review new treatment options for non-healing epithelial defects due to neurotrophic keratitis (NK).

Review the rarest conditions that three ophthalmologists at the top of their field have encountered and pearls for identifying and managing these diseases.

While “dry eye” symptoms are common and well known, accurately diagnosing and properly addressing the various conditions that constitute ocular surface disease can often be challenging. Now, a new aided diagnostic imaging platform makes that aspect of eye care more attainable.

Join John Kitchens, MD, and Michael Klufas, MD, to review pearls and data on the efficacy of next-generation anti-vascular endothelial growth factor (VEGF) drugs.

Review findings from recent studies and clinical trials on surgical interventions and medical therapies to manage proliferative vitreoretinopathy (PVR).

Learn how ophthalmologists can overcome the largest obstacles in opening and maintaining a private practice to sustain long-term practice growth.

Picking an ophthalmology residency is a big decision, especially with 120+ programs to choose from. Use our quiz and guide to kickstart your research process!

In this session from Eyes On 2025, Matthew Bernier, Product Director at Rectangle Health, discusses what eyecare practices stand to gain by investing in technologies to speed up their insurance payments.